These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 9485177
21. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits. Sone T, Miyake M, Takeda N, Fukunaga M. Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404 [Abstract] [Full Text] [Related]
22. Bone metabolism during the perimenopausal transition: a prospective study. Seifert-Klauss V, Mueller JE, Luppa P, Probst R, Wilker J, Höss C, Treumann T, Kastner C, Ulm K. Maturitas; 2002 Jan 30; 41(1):23-33. PubMed ID: 11809340 [Abstract] [Full Text] [Related]
24. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine. Srivastava AK, MacFarlane G, Srivastava VP, Mohan S, Baylink DJ. Calcif Tissue Int; 2001 Dec 30; 69(6):327-36. PubMed ID: 11800229 [Abstract] [Full Text] [Related]
25. Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation. Cauley JA, Danielson ME, Greendale GA, Finkelstein JS, Chang YF, Lo JC, Crandall CJ, Neer RM, Ruppert K, Meyn L, Prairie BA, Sowers MR. Menopause; 2012 Nov 30; 19(11):1200-7. PubMed ID: 22850443 [Abstract] [Full Text] [Related]
26. Monitoring bone loss using ELISA and surface plasmon resonance (SPR) technology. Lung FD, Chen HY, Lin HT. Protein Pept Lett; 2003 Jun 30; 10(3):313-9. PubMed ID: 12871151 [Abstract] [Full Text] [Related]
28. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL. Calcif Tissue Int; 1994 Jan 30; 54(1):26-9. PubMed ID: 8118749 [Abstract] [Full Text] [Related]
30. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis. Garnero P, Delmas PD. Bone; 2003 Jan 30; 32(1):20-6. PubMed ID: 12584032 [Abstract] [Full Text] [Related]
31. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. J Bone Miner Res; 1996 Mar 30; 11(3):337-49. PubMed ID: 8852944 [Abstract] [Full Text] [Related]
37. Biochemical markers as predictors of rates of bone loss after menopause. Rogers A, Hannon RA, Eastell R. J Bone Miner Res; 2000 Jul 30; 15(7):1398-404. PubMed ID: 10893690 [Abstract] [Full Text] [Related]
38. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Aoshima H, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Inoue T. Bone; 1998 Jan 30; 22(1):73-8. PubMed ID: 9437516 [Abstract] [Full Text] [Related]
39. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Hassager C, Risteli J, Risteli L, Christiansen C. Osteoporos Int; 1994 Nov 30; 4(6):349-52. PubMed ID: 7696831 [Abstract] [Full Text] [Related]
40. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age. Lapillonne A, Travers R, DiMaio M, Salle BL, Glorieux FH. Pediatrics; 2002 Jul 30; 110(1 Pt 1):105-9. PubMed ID: 12093954 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]